Genetic Polymorphisms in the HTR2C and Peroxisome Proliferator-Activated Receptors Are Not Associated with Metabolic Syndrome in Patients with Schizophrenia Taking Clozapine
Authors:
Open Access
- 1 January 2011
- journal article
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 8 (3) , 262-268
Abstract
Kang SH, et al. Psychiatry Investig. 2011 Sep;8(3):262-268. http://dx.doi.org/10.4306/pi.2011.8.3.262Keywords
This publication has 38 references indexed in Scilit:
- HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With SchizophreniaJournal of Clinical Psychopharmacology, 2009
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart reviewSchizophrenia Research, 2008
- The Association Between HTR2C Gene Polymorphisms and the Metabolic Syndrome in Patients With SchizophreniaJournal of Clinical Psychopharmacology, 2007
- Antipsychotic induced metabolic abnormalities: An interaction study with various PPAR modulators in miceLife Sciences, 2006
- The V227A polymorphism at the PPARA locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese womenAtherosclerosis, 2006
- Association of V227A PPARα polymorphism with altered serum biochemistry and alcohol drinking in Japanese menPharmacogenetics and Genomics, 2006
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Roles of peroxisome proliferator-activated receptor delta (PPARδ) in the control of fatty acid catabolism. A new target for the treatment of metabolic syndromeBiochimie, 2004
- Changes in Glucose and Cholesterol Levels in Patients With Schizophrenia Treated With Typical or Atypical AntipsychoticsAmerican Journal of Psychiatry, 2003
- Prospective analysis of the insulin-resistance syndrome (syndrome X)Diabetes, 1992